These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 32923139)
1. Modeling human pediatric and adult gliomas in immunocompetent mice through costimulatory blockade. Lan X; Kedziorek DA; Chu C; Jablonska A; Li S; Kai M; Liang Y; Janowski M; Walczak P Oncoimmunology; 2020 Jun; 9(1):1776577. PubMed ID: 32923139 [TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
3. An immunocompetent mouse model of human glioblastoma. Semenkow S; Li S; Kahlert UD; Raabe EH; Xu J; Arnold A; Janowski M; Oh BC; Brandacher G; Bulte JWM; Eberhart CG; Walczak P Oncotarget; 2017 Sep; 8(37):61072-61082. PubMed ID: 28977847 [TBL] [Abstract][Full Text] [Related]
4. Glioblastoma spheroids produce infiltrative gliomas in the rat brainstem. Zhou Z; Luther N; Singh R; Boockvar JA; Souweidane MM; Greenfield JP Childs Nerv Syst; 2017 Mar; 33(3):437-446. PubMed ID: 28236065 [TBL] [Abstract][Full Text] [Related]
5. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models. Martínez-Vélez N; Garcia-Moure M; Marigil M; González-Huarriz M; Puigdelloses M; Gallego Pérez-Larraya J; Zalacaín M; Marrodán L; Varela-Guruceaga M; Laspidea V; Aristu JJ; Ramos LI; Tejada-Solís S; Díez-Valle R; Jones C; Mackay A; Martínez-Climent JA; García-Barchino MJ; Raabe E; Monje M; Becher OJ; Junier MP; El-Habr EA; Chneiweiss H; Aldave G; Jiang H; Fueyo J; Patiño-García A; Gomez-Manzano C; Alonso MM Nat Commun; 2019 May; 10(1):2235. PubMed ID: 31138805 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma. Bailey CP; Figueroa M; Gangadharan A; Yang Y; Romero MM; Kennis BA; Yadavilli S; Henry V; Collier T; Monje M; Lee DA; Wang L; Nazarian J; Gopalakrishnan V; Zaky W; Becher OJ; Chandra J Neuro Oncol; 2020 Sep; 22(9):1302-1314. PubMed ID: 32166329 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876 [TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry. Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282 [TBL] [Abstract][Full Text] [Related]
10. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models. Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413 [No Abstract] [Full Text] [Related]
11. Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma. Chornenkyy Y; Agnihotri S; Yu M; Buczkowicz P; Rakopoulos P; Golbourn B; Garzia L; Siddaway R; Leung S; Rutka JT; Taylor MD; Dirks PB; Hawkins C Mol Cancer Ther; 2015 Nov; 14(11):2560-8. PubMed ID: 26351319 [TBL] [Abstract][Full Text] [Related]
12. Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review). Scutti JAB Int J Oncol; 2018 Apr; 52(4):1041-1056. PubMed ID: 29484440 [TBL] [Abstract][Full Text] [Related]
13. Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models. Martinez-Velez N; Marigil M; García-Moure M; Gonzalez-Huarriz M; Aristu JJ; Ramos-García LI; Tejada S; Díez-Valle R; Patiño-García A; Becher OJ; Gomez-Manzano C; Fueyo J; Alonso MM Acta Neuropathol Commun; 2019 Apr; 7(1):64. PubMed ID: 31036068 [TBL] [Abstract][Full Text] [Related]
14. Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture. Caretti V; Jansen MH; van Vuurden DG; Lagerweij T; Bugiani M; Horsman I; Wessels H; van der Valk P; Cloos J; Noske DP; Vandertop WP; Wesseling P; Wurdinger T; Hulleman E; Kaspers GJ Neuropathol Appl Neurobiol; 2013 Jun; 39(4):426-36. PubMed ID: 22845849 [TBL] [Abstract][Full Text] [Related]